According to the company, Romano will lead the company's global clinical development strategy, including oversight of clinical development, clinical operations, biometrics and digital science, and medical affairs functions.
Shares were up about 3% in the after-hours session.
Price: 15.54, Change: +0.47, Percent Change: +3.09
|-- Earnings Flash (AQS) AEQUUS PHARMACEUTICALS Repor...|
|Insider Buy: Bitnile Holdings|
|Insider Buy: Macerich|
|Insider Sell: Velodyne Lidar|
|Insider Sell: Xometry|